期刊文献+

宝山区405例新的/严重的药品不良反应报告分析 被引量:13

Analysis On the 405 New/Serious ADR Cases' Adverse Reaction in Baoshan District
暂未订购
导出
摘要 目的通过药品不良反应(ADR)报告的统计分析,发掘警戒信号,提高药品不良反应监测工作质量,促进临床用药安全。方法选取上海市宝山区2010年1~6月份上报的新的严重的ADR报告表405例,采用EXCEL电子表格和手工筛选方法,从多个维度进行统计分析。结果 405例ADR中,60岁以上患者192例(47.1%);引起ADR的药品主要是中药制剂156例(37.8%),抗微生品药140例(33.9%);用药途径中静脉注射239例(57.7%);ADR主要累及消化系统、皮肤和神经系统,分别占34.1%、22.3%和20.9%。结论 ADR的发生与诸多因素相关,包括患者年龄、药品种类和给药途径等,特别要重视中药制剂和抗微生物药品的不良反应监测,临床表现也呈现多元化,应加强ADR的监测,科学合理用药,确保用药的安全、有效。 Objective To explore the warning signal, improve the quality of adverse drug reaction(ADR) supervision and promote clinical drug safety through the statistical analysis of adverse drug reaction(ADR). Methods Choose the new & serious 405 ADRs cases in Baoshan District from January to June in 2010 as a sample, on which do statistical analysis in various ways by EXCEL and manual screening. Results In the 405 cases, including 192 cases who are over 60a(47.1%), ADRs are mainly caused by Chinese patent medicines(37.8%), anti-microbiology medicine(33.9%) and intravenous injection(57.7%). ADRs mainly affects the digestive system, skin and nervous system ,which respectively accounted for 34.1%,22.3% and 20.9%. Conclusion ADRs are caused by many factors, including patient's age, drug types and the way of use, It nmst pay great attention to Chinese patent medicines and anti-microbiology medicine. The clinical manifestation is also becoming more and more pluralistic. Therefore, we should strengthen the monitoring method and rational use of drugs to ensure medication safety and efficiency.
作者 李 盛红彬
出处 《中国药物警戒》 2011年第12期755-758,共4页 Chinese Journal of Pharmacovigilance
关键词 药品不良反应(ADR) 药物警戒 合理用药 ADR pharmacovigilance rational drug use
  • 相关文献

参考文献6

二级参考文献17

共引文献153

同被引文献104

  • 1杨华,林焕泽,吴秀荣.茂名地区2007-2009年抗菌药物致不良反应报告分析[J].中国药房,2011,22(6):533-535. 被引量:12
  • 2何娟,方洁,陈冰,杨婉花.我院187例药品不良反应报告分析[J].中国药房,2011,22(14):1312-1314. 被引量:12
  • 3张象麟.药物临床信息参考2008[M].重庆:重庆出版社.2008,1-36.
  • 4国家药品不良反应监测中心,国家食品药品监督管理局药品评价中心.WHO药品不良反应术语集[M].北京:中国医药科技出版社,2003:1.
  • 5Hossein K, Niayesh M, Narjes H. Improvement of knowl edge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists" interventional study[J]. BMJ open 2012, 2(1) =367.
  • 6L6vborg H, Eriksson LR, Jonsson AK, et al. A prospective analysis of the preventability of adverse drug reactions reported in Sweden[J]. Eur J Clin Pharmacol, 2012,19 : 1-7.
  • 7Pirmohamed M, James S, Meakin S, et al. Adverse drug reac- tions as cause of admission to hospital: prospective analysis of 18 820 patients[J]. BMJ,2004,329(3): I5-19.
  • 8Thomsen I.A, Winterstein AG,Sondergaard B, et al. System- atic review of the incidence and characteristics of preventable adverse drug events in ambulatory care[J]. Ann Pharmaeoth- er, 2007, 41(9): 1411 1126.
  • 9国家药品不良反应中心,国家食品药品监督管理局药品评价中心.WHO药品不良反应术语集[M].北京:中国医药科技出版社,2002:1-172.
  • 10Bate A, Lindquist M, Edwards I R, et al. A data mining approach for signal detection and analysis[J]. Drug Safety, 2002, 25(6): 393-397.

引证文献13

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部